[go: up one dir, main page]

MX2021003154A - Composiciones y métodos para tratar celulitis. - Google Patents

Composiciones y métodos para tratar celulitis.

Info

Publication number
MX2021003154A
MX2021003154A MX2021003154A MX2021003154A MX2021003154A MX 2021003154 A MX2021003154 A MX 2021003154A MX 2021003154 A MX2021003154 A MX 2021003154A MX 2021003154 A MX2021003154 A MX 2021003154A MX 2021003154 A MX2021003154 A MX 2021003154A
Authority
MX
Mexico
Prior art keywords
compositions
methods
treating cellulite
cellulite
treating
Prior art date
Application number
MX2021003154A
Other languages
English (en)
Inventor
Michael Mclane
Matthew W Davis
Original Assignee
Endo Global Aesthetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2019/000767 external-priority patent/WO2020021330A2/en
Priority claimed from PCT/IB2019/000777 external-priority patent/WO2020021332A2/en
Application filed by Endo Global Aesthetics Ltd filed Critical Endo Global Aesthetics Ltd
Publication of MX2021003154A publication Critical patent/MX2021003154A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24007—Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Image Processing (AREA)

Abstract

La presente descripción se refiere a un método para tratar la celulitis en un muslo o glúteo en un sujeto humano mediante la administración de una cantidad efectiva de colagenasa, y luego evaluar la reducción de la gravedad de la celulitis mediante una o más escalas.
MX2021003154A 2018-09-18 2019-09-04 Composiciones y métodos para tratar celulitis. MX2021003154A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862733046P 2018-09-18 2018-09-18
US201962788916P 2019-01-06 2019-01-06
US201962812036P 2019-02-28 2019-02-28
US201962823596P 2019-03-25 2019-03-25
PCT/IB2019/000767 WO2020021330A2 (en) 2018-07-12 2019-07-11 Injection techniques for the treatment of cellulite
PCT/IB2019/000777 WO2020021332A2 (en) 2018-07-12 2019-07-12 Injection techniques for the treatment of cellulite
PCT/IB2019/000955 WO2020058755A1 (en) 2018-09-18 2019-09-04 Compositions and methods for treating cellulite

Publications (1)

Publication Number Publication Date
MX2021003154A true MX2021003154A (es) 2021-06-23

Family

ID=69888399

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021003154A MX2021003154A (es) 2018-09-18 2019-09-04 Composiciones y métodos para tratar celulitis.

Country Status (10)

Country Link
US (1) US20240277595A1 (es)
EP (1) EP3852715A1 (es)
JP (2) JP7628492B2 (es)
KR (1) KR20210079291A (es)
CN (1) CN113015514A (es)
AU (2) AU2019341663B2 (es)
CA (1) CA3112437A1 (es)
IL (1) IL281501A (es)
MX (1) MX2021003154A (es)
WO (1) WO2020058755A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4522283A1 (en) * 2022-05-10 2025-03-19 Endo Global Aesthetics Limited Methods of reducing collagenase-mediated bruising in a subject having cellulite

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
WO2008101406A1 (en) * 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
FI3581199T3 (fi) * 2011-10-21 2023-08-18 Endo Global Ventures Menetelmiä turvottavan fibroskleroottisen pannikulopatian hoitamiseksi tai vähentämiseksi
CA2970639C (en) 2012-01-12 2022-04-26 Auxilium International Holdings, Inc. Clostridium histolyticum enzymes and methods for the use thereof
CA2907255C (en) 2013-03-15 2021-09-21 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
US9996923B2 (en) 2015-04-24 2018-06-12 Canfield Scientific, Incorporated Methods and apparatuses for dermatological feature tracking over multiple images
WO2018116305A1 (en) 2016-12-22 2018-06-28 Eva - Esthetic Visual Analytics Ltd. Real-time tracking for three-dimensional imaging
US10999569B2 (en) 2016-12-22 2021-05-04 Eva—Esthetic Visual Analytics Ltd. Three-dimensional image reconstruction using multi-layer data acquisition
IL301796A (en) * 2017-03-01 2023-05-01 Endo Ventures Ltd Method for assessing and treating cellulite
WO2019023402A1 (en) 2017-07-26 2019-01-31 Canfield Scientific, Incorporated METHOD AND APPARATUS FOR AUTOMATIC GENERATION AND MONITORING OF NORMALIZED ANATOMICAL REGIONS

Also Published As

Publication number Publication date
JP2025081344A (ja) 2025-05-27
AU2025202468A1 (en) 2025-04-24
AU2019341663B2 (en) 2025-01-09
BR112021005064A2 (pt) 2021-06-08
IL281501A (en) 2021-04-29
WO2020058755A1 (en) 2020-03-26
CA3112437A1 (en) 2020-03-26
JP2022502478A (ja) 2022-01-11
AU2019341663A1 (en) 2021-04-22
CN113015514A (zh) 2021-06-22
US20240277595A1 (en) 2024-08-22
EP3852715A1 (en) 2021-07-28
JP7628492B2 (ja) 2025-02-10
KR20210079291A (ko) 2021-06-29

Similar Documents

Publication Publication Date Title
MX2023008072A (es) Metodo para la evaluacion y el tratamiento de la celulitis.
WO2019006005A3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
PH12019501010A1 (en) Arginase inhibitor combination therapies
PH12017500070A1 (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
MD4685B1 (ro) Metodă de tratament al stărilor asociate cu activarea complementului dependentă de MASP-2
MY201811A (en) Method of reducing neutropenia
MX370624B (es) Composiciones que incluyen extractos de ampelopsis grossedentata y albizia julibrissin y métodos para uso.
MX2018008855A (es) Composicion que comprende toxina botulinica.
NZ727407A (en) Methods and compositions of bile acids and salts for reduction of fat
MX2020002216A (es) Metodos y composiciones para detectar y tratar endometriosis.
MX2020011817A (es) Metodos para tratar el linfoma.
MX379222B (es) Composición para promover la diferenciación y protección de células madre neurales y método para inducir la regeneración neural usando las mismas.
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
NZ738389A (en) Inhibitor of igfbp3/tmem219 axis and diabetes
MX2019013862A (es) Terapia de combinacion.
PH12021552866A1 (en) Compositions and methods for treating cancer
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
MX2020002702A (es) Metodo de tratamiento.
MX2021003154A (es) Composiciones y métodos para tratar celulitis.
MX2021000380A (es) Tecnicas de inyeccion para el tratamiento de la celulitis.
WO2020021332A3 (en) Injection techniques for the treatment of cellulite
MX2020001546A (es) Uso de inhibidores de braf para tratar reacciones cutaneas causadas por el tratamiento con un inhibidor de mek.
MX375382B (es) Métodos y composiciones de uso para el tratamiento de la degeneración de tendón.
MX2021015034A (es) Composiciones de lactobacillus y usos de las mismas.
IN2015KN00370A (es)